Inflammatory Breast Cancer: a Separate Entity.

Rosenbluth, Jennifer M; Overmoyer, Beth A

Rosenbluth, Jennifer M; Overmoyer, Beth A.

Affiliation

Rosenbluth JM; Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Overmoyer BA; Susan F. Smith Center for Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Beth_overmoyer@dfci.harvard.edu.

Curr Oncol Rep ; 21(10): 86, 2019 08 15.

Article in En | MEDLINE | ID: mdl-31414257

Subject(s)

Inflammatory Breast Neoplasms/pathology; Inflammatory Breast Neoplasms/therapy; Female; Humans; Inflammatory Breast Neoplasms/classification; Prognosis

Key words

Clinical trials; Dermal lymphatic invasion; Inflammatory breast cancer; Locally advanced breast cancer; Tumor emboli

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Curr Oncol Rep Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google